Last Updated: Monday, August 12, 2013, 12:39
GGL is a subsidiary of Mumbai-based Glenmark Pharmaceuticals Ltd.
Last Updated: Thursday, August 01, 2013, 20:05
Drug firm Glenmark Pharmaceuticals Thursday reported a 64.39 percent rise in its consolidated net profit at Rs 128.67 crore for the first quarter ended June 30, 2013 mainly on account of robust sales.
Last Updated: Thursday, August 01, 2013, 16:59
The Delhi High Court on Thursday reserved its verdict on US drug major Merck Sharp and Dohme's (MSD) appeal against a single judge bench order refusing to restrain Indian firm Glenmark from manufacturing and selling anti-diabetes drugs Zita and Zita-Met.
Last Updated: Tuesday, July 02, 2013, 13:46
According to IMS Health, for the 12 month period ending March 2013, Rizatriptan ODT achieved sales of USD 263 million.
Last Updated: Friday, June 21, 2013, 20:46
India's Sun Pharmaceutical Industries and Glenmark Generics have got approval from US health regulator to sell generic versions of nervous system disorder treatment drug Riluzole.
Last Updated: Wednesday, June 19, 2013, 12:34
Drug firm Glenmark Pharmaceuticals on Wednesday said it has received US health regulator's approval to market Riluzole tablets, used in treating nervous system disorder, in the American market.
Last Updated: Thursday, May 23, 2013, 19:47
A notification issued by US Food and Drug Administration said that the drug major has initiated voluntary recall of its Gabapentin Tablets 600mg.
Last Updated: Wednesday, May 15, 2013, 15:26
Glenmark's current portfolio consists of 85 products authorised for distribution in the US market.
Last Updated: Friday, April 12, 2013, 15:16
A bench of Justices S Ravindra Bhat and S K Mishra issued a notice to Glenmark and sought its reply by May 22 on the US firm's plea challenging the single judge order.
Last Updated: Wednesday, April 10, 2013, 14:08
A bench of justices Sanjay Kishan Kaul and Indermeet Kaur took the plea of US pharma major on record and posted it for hearing before another bench on April 12.
Last Updated: Tuesday, April 09, 2013, 21:51
US pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court challenging its single bench order refusing to grant interim relief to it on a patent row against Indian firm Glenmark Pharmaceuticals.
Last Updated: Friday, April 05, 2013, 15:18
Merck & Co sued Mumbai-based Glenmark for infringing on its patents for two diabetes drugs Januvia and Janumet.
more videos >>